In a retrospective exploration of significant strides in pharmaceutical formulation technology, Nikko Chemicals proudly acknowledges the distinguished researcher, Mr. Kingo Uji, for his exceptional contributions. The awarded 29th "The Master of Pharmaceutical Technology" honour by The Academy of Pharmaceutical Science and Technology, Japan, serves as a testament to Mr. Uji's outstanding work in advancing pharmaceutical formulations.
Of particular note is Mr. Uji's emergence from the raw material industry, a facet that distinguishes his accomplishments. His expertise spans the intricate science of formulating quasi-pharmaceutical products and external-use medicines, showcasing unwavering commitment during his tenure at Nikko Chemicals.
As a lecturer at Nikko Chemicals’ Open Laboratory, Mr. Uji played a pivotal role in disseminating knowledge and expertise to over 2,000 researchers, not only within Japan but globally. His enduring legacy includes decades of contributions through lectures and seminars at The Academy of Pharmaceutical Science and Technology, Japan, and the Japan Society of Pharmaceutical Machinery and Engineering.
Reflecting on his journey, Mr. Uji recalls the challenges and triumphs inherent in the development of formulations. Collaborative problem-solving, fuelled by shared experiences with colleagues and customers, played a pivotal role in his success.
In the spirit of perpetual innovation, Mr. Uji remained steadfast in providing updated information and technology to customers. His recent role as a lecturer at the "Semi-solid Preparation Workshop," organised by the Japan Society of Pharmaceutical Machinery and Engineering, further underscores his commitment to knowledge dissemination.
Nikko Chemicals' strategic merger with Cosmos Technical Center Co., Ltd. in April 2022 marked a turning point, ushering in an era of integrated sales and research and development. This collaborative venture introduced a comprehensive business unit organisational system, encompassing the Personal Care Business Unit, the Pharmaceutical Business Unit, the Chemical Business Unit, and the Innovative Business Planning Division.
The Pharmaceuticals Business Unit, drawing on years of expertise in colloid chemistry and skin science technology, continued to provide high-quality raw materials for the external drug market. The vision was to share this wealth of knowledge with other pharmaceutical businesses, fostering collaboration and creating new value in the industry.
As we reflect on the achievements of the past year, the Pharmaceuticals Business Unit at Nikko Chemicals stands as an enduring symbol of technological prowess, dedicated to shaping the landscape of pharmaceutical advancements within the cosmetic industry.
